S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

Schmoll, H; Wittig, BW; Arnold, DA; Riera-Knorrenschild, JRK; Nietsche, DN; Kroening, HK; Mayer, FM; Andel, JA; Ziebermayr, RZ; Scheithauer, WS

doi:10.1186/2051-1426-2-S2-I2

Article metrics
Last updated: Fri, 26 Apr 2024 13:37:58 Z

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

Access & Citations

1312

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.